Tonix Pharmaceuticals Holding Corp. (TNXP)
Last updated: 2026-10-21 23:53:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.44, with a market capitalization of $98.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.39 to $20.58. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$98.28M | |
$5.44 | |
$13,440,000,000.00 | |
$5.39 | |
$5.78 | |
340.94K | |
624.83K | |
-- | |
$20.58 | |
$5.39 | |
-- | |
-- |
Tonix Pharmaceuticals Holding Corp. (TNXP) After-Hours Stock Price
Tonix Pharmaceuticals Holding Corp. (TNXP) is trading at $5.43 in after-hours trading as of 2026-10-21 23:47:00, down 6.07% ($0.35) from the regular-session close of $5.78.
After-hours trading shows how investors are pricing TNXP after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Tonix Pharmaceuticals Holding Corp. (TNXP) 7-Day Stock Price Change
Over the past seven days, Tonix Pharmaceuticals Holding Corp. (TNXP) moved from $6.64 to $5.44, representing a decline of 18.03% ($1.20).
The stock traded between $5.39 and $7.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.27 million shares, up versus the previous seven-day period, indicating higher trading activity.
TNXP 52-Week Price Position
Position in Range: 0.3%
TNXP is currently trading at $5.44, placing it 0.3% of the way from its 52-week low of $5.39 to its 52-week high of $20.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tonix Pharmaceuticals Holding Corp. (TNXP)?
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
Tonix Pharmaceuticals Holding Corp. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 142 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tonix Pharmaceuticals Holding Corp. (TNXP) Stock on MEXC
Eligible investors can buy real shares of Tonix Pharmaceuticals Holding Corp. (TNXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tonix Pharmaceuticals Holding Corp. (TNXP) stock price today?
2.Is TNXP stock going up or down today?
3.What is TNXP pre-market price?
4.What is TNXP after-hours price?
5.Is TNXP stock trading now?
6.Where does TNXP sit relative to its 52-week high and low?
7.What sector is Tonix Pharmaceuticals Holding Corp. in?
8.What is Tonix Pharmaceuticals Holding Corp.'s market capitalization and where is it listed?
9.How is TNXP valued in terms of P/E ratio and EPS?
10.Does Tonix Pharmaceuticals Holding Corp. pay a dividend?
Explore More US Stocks
Search Stocks
TNXP Stock Calculator
Estimate the value between TNXP shares and USD.
TNXP Shares to USD
1.00 TNXP shares = 5.443 USD
Calculations are estimates based on the latest available price and are for reference only.


